New therapy teplizumab could delay type 1 diabetes by years – if caught early

By Richard Oram, Professor of Diabetes and Nephrology, University of Exeter
Nicholas Thomas, Clinical Lecturer, Diabetes and Endocrinology, University of Exeter

For more than a century, type 1 diabetes has meant one thing: a lifetime administering insulin. But for the first time, science is breaking that paradigm – not by managing the disease, but by intercepting it before symptoms even appear.

As the first patients in the UK begin receiving the groundbreaking new therapy, teplizumab, we are developing ways to identify who might benefit from a drug that only works if given before any symptoms appear. At the Royal Devon NHS, we are currently treating the first UK…

Read complete article

~	Envoy’s plan to fight antisemitism would put universities on notice over funding

~	Skorts revolutionised how women and girls play sport. But in 2025, are they regressive?

~	Politics with Michelle Grattan: Larissa Waters on why we deserve more than a government that just tinkers

~	First the dire wolf, now NZ’s giant moa: why real ‘de-extinction’ is unlikely to fly

~	UK: Government’s unchecked use of tech and AI systems leading to exclusion of people with disabilities and other marginalized groups

~	Emptying Moldova: the four waves of Moldovan emigration

~	Two books on the mushroom trial are already cooking. What are the risks and rewards of fast books on big news?

~	How can we stay safe after data breaches? Step 1 is to change the cybersecurity laws

~	That $20 dress direct from China now costs $30 after Trump closed a tariff loophole – and the US will soon end the ‘de minimis’ exemption for the rest of the world, too

~	Melting ice will strengthen the monsoon in northern Australia – but cause drier conditions north of the Equator